导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 23.42% | 568/969 |
| 近一周 | -2.19% | 784/1048 |
| 近一月 | -3.05% | 643/1046 |
| 近一季 | 5.68% | 176/1033 |
| 近半年 | 17.74% | 561/1007 |
| 近一年 | 24.55% | 464/964 |
| 近两年 | 36.76% | 405/880 |
| 近三年 | 9.03% | 435/780 |
| 成立以来 | 18.60% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
2.38% 614/1014 |
3.32% 411/1038 |
11.43% 829/1050 |
- - |
| 2024 | 9.87% 294/1011 |
6.61% 68/960 |
2.83% 160/983 |
5.89% 860/991 |
-5.35% 689/1011 |
| 2023 | -18.09% 623/952 |
-1.87% 707/880 |
-8.67% 718/895 |
-0.67% 104/915 |
-7.99% 756/952 |
| 2022 | -29.57% 618/867 |
-20.16% 525/773 |
14.02% 146/806 |
-13.05% 467/845 |
-11.02% 805/867 |
| 2021 | -6.98% 450/740 |
-2.48% 243/580 |
10.40% 345/659 |
-10.15% 513/704 |
-3.83% 562/740 |
| 2020 | - - |
- - |
11.73% 387/466 |
23.19% 29/517 |
20.08% 117/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 创金合信全球医药生物股票发起(QDII)C | 1.8048 | 37.74% |
| 泰信现代服务业混合 | 2.0450 | 32.88% |
| 易方达标普生物科技人民币A | 1.7298 | 28.02% |
| 永赢高端装备智选混合发起A | 1.1625 | 27.65% |
| 永赢高端装备智选混合发起C | 1.1467 | 27.52% |
| 金信稳健策略混合A | 2.2741 | 23.08% |
| 金信精选成长混合A | 1.6584 | 22.49% |
| 金信精选成长混合C | 1.6361 | 22.31% |
| 东方人工智能主题混合C | 1.5534 | 22.12% |
| 金信行业优选混合发起式A | 2.7474 | 21.61% |
| 民生加银龙头优选股票A VS. () |